We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Stent Data Affects Diabetic Device Markets, Report Says
Stent Data Affects Diabetic Device Markets, Report Says
September 7, 2007
The U.S. market for diabetic vascular disease devices is valued at more than $1.25 billion this year, but future growth will be limited by negative clinical studies surrounding coronary drug-eluting stents and more aggressive medical management, according to a recent report from Millennium Research Group (MRG).